Bright Lights Conference Will Showcase 50 of the Most Innovative U.S. Small Cap Companies with Disruptive Intellectual Property in San Francisco...
NORWOOD, Mass., Jan. 12 /PRNewswire/ -- Molecular BiometricsĀ®, Inc., a metabolomics company developing novel clinical diagnostic tools for...
New Molecular Tests and Increased Case Volume Continue to Drive Revenue Growth ALISO VIEJO, Calif., May 6 /PRNewswire-FirstCall/ -- Clarient...
The Clarient Insight(R) Dx Breast Cancer Profile Assists Physicians In Identifying Recurrence Risk and the Need for Chemotherapy ALISO VIEJO...
FOXA1 biomarker predicts likelihood of recurrence and long-term disease-free survival of breast cancer patients; Further strengthens Company's...
Presentation Scheduled for 8:45am EDT ALISO VIEJO, Calif., March 12 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier technology...
New Molecular Tests and Increasing Case Volumes Drive 78 Percent Revenue Growth in the Fourth Quarter of 2008 as Compared to the Prior Year Period...
- Augments Senior Management Team with more than 30 Years Experience in Biopharmaceutical Manufacturing, Engineering, Technical Services and...
Amendment extends lease through 2016 with options through 2026 PRINCETON, N.J., April 25 /PRNewswire/ -- Laureate Pharma, Inc., a full- service...
Former Microsoft Executive to Assume Key Management Position NORWALK, Conn., April 10 /PRNewswire-FirstCall/ -- EDGAR(R) Online, Inc...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads